According to EKF Diagnostics's latest financial reports the company's current EPS (TTM) is $0.006625. In 2023 the company made an earnings per share (EPS) of $0.006625 an increase over its 2022 EPS that were of -$0.02674.
Year | EPS | Change |
---|---|---|
2023 | $0.006625 | -124.78% |
2022 | -$0.02674 | -157.08% |
2021 | $0.04684 | 40.26% |
2020 | $0.03340 | 214.41% |
2019 | $0.01062 | -62.14% |
2018 | $0.02805 | 251.81% |
2017 | $0.007974 | -16255.8% |
2016 | -$0.00004936 | -99.96% |
2015 | -$0.13 | 458.41% |
2014 | -$0.02335 | 245.31% |
2013 | -$0.006763 | -158.93% |
2012 | $0.01148 | -154.69% |
2011 | -$0.02098 | -61.27% |
2010 | -$0.05418 | 458.07% |
2009 | -$0.009709 | -83.01% |
2008 | -$0.05716 | -305.51% |
2007 | $0.02781 | -21.12% |
2006 | $0.03526 | -11.11% |
2005 | $0.03966 | -208.74% |
2004 | -$0.03648 | 19.95% |
2003 | -$0.03041 | -179.02% |
2002 | $0.03848 | 1227.04% |
2001 | $0.002900 |